CBIO 8-K: SEC filing

Filed with the SEC on · accession 0001628280-26-073409

CBIO filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -2.6% by the first close after the filing.

Summary of the filing

Crescent Biopharma, Inc. furnished a Form 8-K under Item 2.02 announcing its financial results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.

Key details

RegistrantCrescent Biopharma, Inc.
Chief executive officerJoshua Brumm

How CBIO stock reacted

Close before

$14.76

Nov 11, 2026

First close after

-2.61%

$14.37

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CBIO?

Click here

Frequently asked questions

What did CBIO file with the SEC on Nov 12, 2026?

CBIO filed a 8-K (SEC filing). Crescent Biopharma, Inc. furnished a Form 8-K under Item 2.02 announcing its financial results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CBIO stock react to this filing?

CBIO closed at $14.76 before the filing and $14.37 on Nov 12, 2026 (-2.61%).

Other CBIO SEC filings

Get alerts when CBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days